Coronavirus (COVID-19) Update: May 28, 2021
http://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-may-28-2021

FDA Seeks $6.5 Billion to Further Investments in Critical Public Health Infrastructure, Core Food Safety and Medical Product Safety Programs
http://www.fda.gov/news-events/press-announcements/fda-seeks-65-billion-further-investments-critical-public-health-infrastructure-core-food-safety-and

FDA Approves First Targeted Therapy for Lung Cancer Mutation Previously Considered Resistant to Drug Therapy
http://www.fda.gov/news-events/press-announcements/fda-approves-first-targeted-therapy-lung-cancer-mutation-previously-considered-resistant-drug

http://www.fda.gov/medical-devices/medical-device-recalls/lepu-medical-technology-recalls-sars-cov-2-antigen-rapid-test-kit-and-leccurate-sars-cov-2-antibody

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/dash-xclusive-issues-voluntary-nationwide-recall-imperia-elita-vitaccino-coffee-due-presence-0

http://www.fda.gov/medical-devices/medical-device-recalls/step-har-medical-recalls-alaris-infusion-pump-module-8100-bezel-due-possible-cracked-or-separated

https://www.ministeriodesalud.go.cr/index.php/centro-de-prensa/noticias/746-noticias-2021/2105-dolor-de-cabeza-coincide-como-el-efecto-secundario-mas-frecuente-luego-de-vacunacion-contra-covid-19-de-pfizer-y-astrazeneca

Sandoz-Irbesartan/HCT Product Recall (2021-05-27)
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/75699r-eng.php

Sandoz-Irbesartan Product Recall (2021-05-27)
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/75701r-eng.php

http://www.fda.gov/medical-devices/letters-health-care-providers/update-fda-recommends-transition-use-non-niosh-approved-and-decontaminated-disposable-respirators